Afya Limited (NASDAQ:AFYA) Receives $28.74 Consensus Price Target from Brokerages


Share on StockTwits

Afya Limited (NASDAQ:AFYA) has received a consensus recommendation of “Hold” from the eight brokerages that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $28.74.

Several analysts recently issued reports on AFYA shares. UBS Group raised Afya from a “neutral” rating to a “buy” rating in a report on Wednesday, April 21st. Zacks Investment Research downgraded Afya from a “hold” rating to a “sell” rating in a research note on Thursday, April 29th. JPMorgan Chase & Co. raised Afya from a “neutral” rating to an “overweight” rating and set a $34.00 target price on the stock in a research note on Thursday, February 4th. Finally, TheStreet downgraded Afya from a “c-” rating to a “d” rating in a research note on Tuesday, March 23rd.

Shares of NASDAQ AFYA traded down $0.64 during mid-day trading on Thursday, hitting $21.18. The company had a trading volume of 459,319 shares, compared to its average volume of 223,496. The stock has a market cap of $1.90 billion, a price-to-earnings ratio of 29.40 and a beta of 1.29. Afya has a 12 month low of $16.85 and a 12 month high of $29.01. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.39 and a quick ratio of 2.38. The firm’s 50 day simple moving average is $21.32 and its two-hundred day simple moving average is $23.75.

Afya (NASDAQ:AFYA) last announced its quarterly earnings results on Wednesday, April 7th. The company reported $0.89 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.58 by ($0.69). The company had revenue of $64.01 million during the quarter. Afya had a return on equity of 13.38% and a net margin of 26.75%. Equities analysts forecast that Afya will post 0.74 earnings per share for the current year.

Several hedge funds have recently modified their holdings of AFYA. US Bancorp DE increased its position in shares of Afya by 61.5% during the 1st quarter. US Bancorp DE now owns 2,022 shares of the company’s stock valued at $38,000 after purchasing an additional 770 shares during the period. AJO LP acquired a new position in shares of Afya during the 4th quarter valued at $57,000. ExodusPoint Capital Management LP increased its position in shares of Afya by 76.3% during the 4th quarter. ExodusPoint Capital Management LP now owns 14,086 shares of the company’s stock valued at $356,000 after purchasing an additional 6,094 shares during the period. Coronation Fund Managers Ltd. increased its position in shares of Afya by 27.5% during the 4th quarter. Coronation Fund Managers Ltd. now owns 15,829 shares of the company’s stock valued at $400,000 after purchasing an additional 3,411 shares during the period. Finally, Engineers Gate Manager LP acquired a new position in shares of Afya in the 4th quarter worth $722,000. Institutional investors own 32.14% of the company’s stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Further Reading: How is diluted EPS different from basic EPS?

Analyst Recommendations for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.